发明公开
EP1276711A2 SYNTHESIS OF MIDODRINE HCI FROM A NOVEL INTERMEDIATE 1-(2',5'-DIMETHOXYPHENYL)-2-AZIDOETHANONE
有权
盐酸米多君的合成从中间1-(2'.5'二甲氧基苯基)-2-叠氮基乙酮
- 专利标题: SYNTHESIS OF MIDODRINE HCI FROM A NOVEL INTERMEDIATE 1-(2',5'-DIMETHOXYPHENYL)-2-AZIDOETHANONE
- 专利标题(中): 盐酸米多君的合成从中间1-(2'.5'二甲氧基苯基)-2-叠氮基乙酮
-
申请号: EP01931614.0申请日: 2001-04-17
-
公开(公告)号: EP1276711A2公开(公告)日: 2003-01-22
- 发明人: RAY, Anup Kumar , PATEL, Hiren Kumar V. , PATEL, Mahendra, R.
- 申请人: Novartis AG
- 申请人地址: Lichtstrasse 35 4056 Basel CH
- 专利权人: Novartis AG
- 当前专利权人: Novartis AG
- 当前专利权人地址: Lichtstrasse 35 4056 Basel CH
- 代理机构: Gros, Florent
- 优先权: US550417 20000417
- 国际公布: WO01079154 20011025
- 主分类号: C07C231/14
- IPC分类号: C07C231/14 ; C07C237/08 ; C07C247/10
摘要:
Midodrine hydrochloride, ± 1-(2',5'-dimethoxyphenyl)-2-glycineamido-ethanol-(1)- HCI, is prepared from a novel intermediate, 1-(2',5'-dimethoxyphenyl)-2-azidoethanone.
公开/授权文献
信息查询